Bank & Trust Company’s Gilead Sciences GILD Stock Holding History

Bank & Trust Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$769K	Buy	6,090 +249	+4%	+$32.8K	0.49%	51
2026 Q1	$814K	Sell	5,841 -54	-0.9%	-$7.56K	0.55%	48
2025 Q4	$724K	Hold	5,895	–	–	0.51%	52
2025 Q3	$654K	Hold	5,895	–	–	0.48%	60
2025 Q2	$654K	Hold	5,895	–	–	0.52%	58
2025 Q1	$661K	Sell	5,895 -70	-1%	-$7.22K	0.54%	55
2024 Q4	$551K	Hold	5,965	–	–	0.46%	60
2024 Q3	$500K	Sell	5,965 -35	-0.6%	-$2.67K	0.41%	62
2024 Q2	$412K	Buy	+6,000	New	+$400K	0.35%	67

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Bank & Trust Company's GILD Position: Q2 2026 in Review

Bank & Trust Company increased its Gilead Sciences (GILD) stake by 4.3% in Q2 2026, buying an estimated $32.8K and bringing the position to 6,090 shares worth $769K. The position accounts for 0.49% of the portfolio, ranked #51.

Bank & Trust Company first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $814K in Q1 2026. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Bank & Trust Company held 6,090 shares of Gilead Sciences worth $769K as of Q2 2026.
Bank & Trust Company bought 249 Gilead Sciences shares in Q2 2026, an estimated $32.8K.
Gilead Sciences made up 0.49% of Bank & Trust Company's portfolio in Q2 2026, its #51 holding.
Bank & Trust Company first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Bank & Trust Company's Gilead Sciences position peaked at $814K in Q1 2026.
1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.